Glenmark Pharmaceuticals LimitedNSE: GLENMARK

Glenmark Pharmaceuticals Limited Press Release Jul 06 2026

· Issued by Glenmark Pharmaceuticals Limited via NSE India

Glenmark Pharmaceuticals Limited has informed the Exchange regarding a press release dated July 06, 2026, titled "Glenmark Pharmaceuticals Inc., USA launches Olanzapine for Injection, 10 mg/vial, Single-Dose Vial".

View Attachment

Earlier from Glenmark Pharmaceuticals

All Glenmark Pharmaceuticals news releases